rs776318939

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2

The NM_000719.7(CACNA1C):​c.3391G>A​(p.Asp1131Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,613,138 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. D1131D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000055 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 missense

Scores

2
8
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 7.70

Publications

0 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP6
Variant 12-2608545-G-A is Benign according to our data. Variant chr12-2608545-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 456964.
BS2
High AC in GnomAdExome4 at 8 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 47 ENST00000399655.6 NP_000710.5
CACNA1CNM_001167623.2 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 47 ENST00000399603.6 NP_001161095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 47 5 NM_001167623.2 ENSP00000382512.1
CACNA1CENST00000399655.6 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 47 1 NM_000719.7 ENSP00000382563.1
CACNA1CENST00000682544.1 linkc.3541G>A p.Asp1181Asn missense_variant Exon 28 of 50 ENSP00000507184.1
CACNA1CENST00000406454.8 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 48 5 ENSP00000385896.3
CACNA1CENST00000399634.6 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 47 5 ENSP00000382542.2
CACNA1CENST00000683824.1 linkc.3556G>A p.Asp1186Asn missense_variant Exon 28 of 48 ENSP00000507867.1
CACNA1CENST00000347598.9 linkc.3451G>A p.Asp1151Asn missense_variant Exon 28 of 49 1 ENSP00000266376.6
CACNA1CENST00000344100.7 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 47 1 ENSP00000341092.3
CACNA1CENST00000327702.12 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 48 1 ENSP00000329877.7
CACNA1CENST00000399617.6 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 48 5 ENSP00000382526.1
CACNA1CENST00000682462.1 linkc.3481G>A p.Asp1161Asn missense_variant Exon 27 of 47 ENSP00000507105.1
CACNA1CENST00000683781.1 linkc.3481G>A p.Asp1161Asn missense_variant Exon 27 of 47 ENSP00000507434.1
CACNA1CENST00000683840.1 linkc.3481G>A p.Asp1161Asn missense_variant Exon 27 of 47 ENSP00000507612.1
CACNA1CENST00000683956.1 linkc.3481G>A p.Asp1161Asn missense_variant Exon 27 of 47 ENSP00000506882.1
CACNA1CENST00000399638.5 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 48 1 ENSP00000382547.1
CACNA1CENST00000335762.10 linkc.3466G>A p.Asp1156Asn missense_variant Exon 28 of 48 5 ENSP00000336982.5
CACNA1CENST00000399606.5 linkc.3451G>A p.Asp1151Asn missense_variant Exon 28 of 48 1 ENSP00000382515.1
CACNA1CENST00000399621.5 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 47 1 ENSP00000382530.1
CACNA1CENST00000399637.5 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 47 1 ENSP00000382546.1
CACNA1CENST00000402845.7 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 47 1 ENSP00000385724.3
CACNA1CENST00000399629.5 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 47 1 ENSP00000382537.1
CACNA1CENST00000682336.1 linkc.3466G>A p.Asp1156Asn missense_variant Exon 28 of 47 ENSP00000507898.1
CACNA1CENST00000399591.5 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 46 1 ENSP00000382500.1
CACNA1CENST00000399595.5 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 46 1 ENSP00000382504.1
CACNA1CENST00000399649.5 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 46 1 ENSP00000382557.1
CACNA1CENST00000399597.5 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 47 1 ENSP00000382506.1
CACNA1CENST00000399601.5 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 47 1 ENSP00000382510.1
CACNA1CENST00000399641.6 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 47 1 ENSP00000382549.1
CACNA1CENST00000399644.5 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 47 1 ENSP00000382552.1
CACNA1CENST00000682835.1 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 47 ENSP00000507282.1
CACNA1CENST00000683482.1 linkc.3382G>A p.Asp1128Asn missense_variant Exon 27 of 47 ENSP00000507169.1
CACNA1CENST00000682686.1 linkc.3391G>A p.Asp1131Asn missense_variant Exon 27 of 46 ENSP00000507309.1
CACNA1CENST00000480911.6 linkn.*1998G>A non_coding_transcript_exon_variant Exon 25 of 27 5 ENSP00000437936.2
CACNA1CENST00000480911.6 linkn.*1998G>A 3_prime_UTR_variant Exon 25 of 27 5 ENSP00000437936.2

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152226
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000321
AC:
8
AN:
249332
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000233
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000548
AC:
8
AN:
1460912
Hom.:
0
Cov.:
31
AF XY:
0.00000275
AC XY:
2
AN XY:
726642
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33462
American (AMR)
AF:
0.000179
AC:
8
AN:
44588
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26102
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39666
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86054
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53354
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111550
Other (OTH)
AF:
0.00
AC:
0
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152226
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41454
American (AMR)
AF:
0.00
AC:
0
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68046
Other (OTH)
AF:
0.000478
AC:
1
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Ventricular tachycardia Uncertain:1
Mar 04, 2019
Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Long QT syndrome Benign:1
Aug 20, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Oct 06, 2023
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
CardioboostArm
Benign
0.00031
BayesDel_addAF
Benign
-0.091
T
BayesDel_noAF
Uncertain
-0.070
CADD
Pathogenic
31
DANN
Uncertain
1.0
DEOGEN2
Benign
0.34
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.;.
Eigen
Uncertain
0.44
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Pathogenic
0.98
D
M_CAP
Uncertain
0.22
D
MetaRNN
Uncertain
0.49
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.79
D
MutationAssessor
Benign
0.89
.;.;.;.;.;.;.;.;.;.;.;L;L;.;.;.;.;.;.;.;.;.;.;.
PhyloP100
7.7
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-0.91
N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;N;.
REVEL
Uncertain
0.57
Sift
Benign
0.43
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;.
Sift4G
Benign
0.66
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
1.0, 1.0, 0.33, 0.0030, 0.15, 0.088, 1.0, 0.91
.;D;D;B;B;B;D;D;D;B;D;D;D;P;D;D;.;D;D;.;.;.;D;.
Vest4
0.82
MutPred
0.54
.;.;.;.;.;.;.;.;.;.;.;Gain of catalytic residue at I1155 (P = 0.0049);Gain of catalytic residue at I1155 (P = 0.0049);.;.;.;.;.;.;.;.;.;.;.;
MVP
0.79
MPC
1.1
ClinPred
0.29
T
GERP RS
4.7
gMVP
0.95
Mutation Taster
=28/72
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs776318939; hg19: chr12-2717711; API